EICHORCondition: Renal Cell Carcinoma · Renal Cell Carcinoma Metastatic · Sponsor: St. Antonius Hospital
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The aim of this study is to evaluate the effect of two decision aids for renal cell carcinoma (RCC) on the decision-making process and the quality of the decision.
This description comes directly from the study's public registry record.
Cato Bresser · 0631143301 · c.bresser@antoniusziekenhuis.nl
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Patients clinically diagnosed with RCC * Patients facing a decision which is addressed in the decision aids (T1 tumor or metastatic disease) * Written informed consent Exclusion Criteria: * Patients who are not able to fill in a questionnaire or undergo an interview individually
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| St. Antonius Ziekenhuis | Nieuwegein, Utrecht, Netherlands | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05548621